Therapeutic plasma exchange for life-threatening pediatric disorders

Jean-Sebastien Diana1,2, Sandra Manceau1,2, Tioka Rabeony3

  • 1Hôpital Necker Enfants Malades, Paris, France.

Insights

Therapeutic plasma exchange (TPE) is a viable treatment for critically ill children, with most adverse events being mild and unrelated to treatment specifics. This study confirms TPE

Area of Science:

  • Pediatric Nephrology
  • Pediatric Hematology
  • Critical Care Medicine

Background:

  • Therapeutic plasma exchange (TPE) is recognized for treating severe pediatric disorders.
  • Research on apheresis in pediatric populations is limited, with few studies featuring adequate patient numbers or control groups.
  • This study aimed to assess the safety and tolerance of TPE in pediatric patients.

Purpose of the Study:

  • To evaluate the tolerance and safety of therapeutic plasma exchange (TPE) in a pediatric cohort.
  • To identify potential risk factors associated with adverse events during TPE in children.
  • To contribute to the limited body of evidence on pediatric apheresis.

Main Methods:

  • Retrospective cohort study analyzing data from pediatric patients who underwent TPE between January 2005 and December 2014.
  • Data collected via a web-based electronic case report form.
  • Analysis included patient demographics, TPE indications, procedure details, and adverse events.

Main Results:

  • 78 pediatric patients underwent 731 TPE procedures for various conditions, including antibody-mediated rejection, thrombotic microangiopathy, and inflammatory diseases.
  • The majority of patients (92%) experienced adverse events (AEs), but most were mild and not linked to specific treatment parameters.
  • No deaths were attributed to the TPE procedure itself.

Conclusions:

  • This study represents one of the largest retrospective analyses of TPE in children to date.
  • TPE is feasible and can be safely administered to pediatric patients with life-threatening and refractory conditions.
  • The findings support the use of TPE in specialized pediatric care settings.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
41
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
18
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
47
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
39
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
78
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
46